Luteal phase support in fresh and frozen embryo transfer cycles

Emre Pabuçcu1, Recai Pabuçcu1,2, Timur Gürgan3,4, Erol Tavmergen5,6
1Ufuk University School of Medicine, Department of Obstetrics and Gynecology, Ankara, Turkey
2Centrum Clinic Assisted Reproduction Center, Ankara, Turkey
3Gürgan Clinic Assisted Reproduction Center, Ankara, Turkey
4Bahçeşehir University School of Medicine, Department of Obstetrics and Gynecology, İstanbul, Turkey
5Tavmergen Clinic Assisted Reproduction Center, İstanbul, Turkey
6Ege University School of Medicine, Department of Obstetrics and Gynecology, Izmir, Turkey

Tài liệu tham khảo

Yanushpolsky, 2015, Luteal phase support in in vitro fertilization, Semin Reprod Med, 33, 118, 10.1055/s-0035-1545363 Rosenberg, 1980, The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone, Fertil Steril, 34, 17, 10.1016/S0015-0282(16)44831-4 Jordan, 1994, Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use, Fertil Steril, 62, 54, 10.1016/S0015-0282(16)56815-0 Devoto, 2009, Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation, Reprod Biomed Online, 18, 19, 10.1016/S1472-6483(10)60444-0 Thomsen, 2018, The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles, Hum Reprod, 33, 1506, 10.1093/humrep/dey226 Van der Linden, 2015, Luteal phase support for assisted reproduction cycles, Cochrane Database Syst Rev, 7 Connell, 2015, Timing luteal support in assisted reproductive technology: a systematic review, Fertil Steril, 103, 939, 10.1016/j.fertnstert.2014.12.125 Csapo, 1972, The significance of the human corpus luteum in pregnancy maintenance: I. Preliminary studies, Am J Obstet Gynecol, 112, 1061, 10.1016/0002-9378(72)90181-0 Kohls, 2012, Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial, Fertil Steril, 98, 858, 10.1016/j.fertnstert.2012.05.046 Watters, 2019, Short versus extended progesterone supplementation for luteal phase support in fresh IVF cycles: a systematic review and meta-analysis, Reprod Biomed Online, S1472-6483 Vaisbuch, 2012, Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey, Reprod Biomed Online, 25, 139, 10.1016/j.rbmo.2012.04.005 Cicinelli, 2004, First uterine pass effect is observed when estradiol is placed in the upper but not lower third of the vagina, Fertil Steril, 81, 1414, 10.1016/j.fertnstert.2003.12.016 Cicinelli, 1999, Transvaginal progesterone: evidence for a new functional ‘“portal system”’ flowing from the vagina to the uterus, Hum Reprod Update, 5, 365, 10.1093/humupd/5.4.365 Bourgain, 1990, Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure, Hum Reprod, 5, 537, 10.1093/oxfordjournals.humrep.a137138 Child, 2018, Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles, Reprod Biomed Online, 36, 630, 10.1016/j.rbmo.2018.02.001 Yanushpolsky, 2010, Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study, Fertil Steril, 94, 2596, 10.1016/j.fertnstert.2010.02.033 Dal Prato, 2008, Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial, Reprod Biomed Online, 16, 361, 10.1016/S1472-6483(10)60597-4 Zarutskie, 2009, A meta-analysis of the route of administrationof luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone, Fertil Steril, 92, 163, 10.1016/j.fertnstert.2009.02.018 Lockwood, 2014, 13 European Centers. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study, Fertil Steril, 101, 112, 10.1016/j.fertnstert.2013.09.010 Baker, 2014, A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization, Hum Reprod, 29, 2212, 10.1093/humrep/deu194 Kuhl, 2005, Pharmacology of estrogens and progestogens: influence of different routes of administration, Climacteric, 8, 3, 10.1080/13697130500148875 Ritzner, 2011, Selectivity and potency of the retroprogesterone dydrogesterone in vitro, Steroids, 76, 607, 10.1016/j.steroids.2011.02.043 Chakravarty, 2005, Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study, J Steroid Biochem Mol Biol, 97, 416, 10.1016/j.jsbmb.2005.08.012 Chakravarty, 2006, Oral dydrogesterone vs. Vaginal micronized progesterone as luteal support in art cycles: evaluation based on hormone profile and clinical outcome, Hum Reprod, 21, i83 Tournaye, 2017, A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, Hum Reprod, 32, 1019, 10.1093/humrep/dex023 Griesinger, 2018, Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial, Hum Reprod, 33, 2212 Barbosa, 2018, Oral dydrogesterone vs. Vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis, JBRA Assist Reprod, 22, 148 Tomic, 2015, Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial, Eur J Obstet Gynecol Reprod Biol, 186, 49, 10.1016/j.ejogrb.2014.11.002 Patki, 2007, Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone, Gynecol Endocrinol, 23, 68, 10.1080/09513590701584857 Ganesh, 2011, Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study, Fertil Steril, 95, 1961, 10.1016/j.fertnstert.2011.01.148 Salehpour, 2013, Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): a randomized clinical trial, Iran J Reprod Med, 11, 913 Saharkhiz, 2016, A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles, Gynecol Endocrinol, 32, 213, 10.3109/09513590.2015.1110136 Rashidi, 2016, Oral dydrogesterone for luteal support in frozen-thawed embryo transfer artificial cycles: a pilot randomized controlled trial, Asian Pac J Reprod, 5, 490, 10.1016/j.apjr.2016.10.002 Versen-Höynck, 2019, Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a Corpus luteum, von Hypertension, 73, 640, 10.1161/HYPERTENSIONAHA.118.12043 Navot, 1991, The window of embryo transfer and the efficiency of human conception in vitro, Fertil Steril, 55, 114, 10.1016/S0015-0282(16)54069-2 Bjuresten, 2011, Luteal phase progesterone increases live birth rate after frozen embryo transfer, Fertil Steril, 95, 534, 10.1016/j.fertnstert.2010.05.019 Veleva, 2013, Factors affecting the outcome of frozen-thawed embryo transfer, Hum Reprod, 28, 2425, 10.1093/humrep/det251 Montagut, 2016, Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues, Hum Reprod, 31, 2803, 10.1093/humrep/dew263 Lee, 2013, Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen- thawed embryo transfer: a retrospective analysis, Eur J Obstet Gynecol Reprod Biol, 169, 50, 10.1016/j.ejogrb.2013.02.005 Casper, 2016, Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support, Fertil Steril, 105, 867, 10.1016/j.fertnstert.2016.01.006 Groenewoud, 2013, What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis, Hum Reprod Update, 19, 458, 10.1093/humupd/dmt030 Seol, 2020, Effect of luteal phase support with vaginal progesterone on pregnancy outcomes in natural frozen embryo transfer cycles: a meta-analysis, Clin Exp Reprod Med Fatemi, 2010, Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle, Fertil Steril, 94, 2054, 10.1016/j.fertnstert.2009.11.036 El Toukhy, 2004, Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study, Hum Reprod, 19, 874, 10.1093/humrep/deh183 Groenewoud, 2016, A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer, Hum Reprod, 31, 1483, 10.1093/humrep/dew120 Lin, 1995, Prediction of early pregnancy outcomes, Int J Gynaecol Obstet, 51, 33, 10.1016/0020-7292(95)80005-W Maheshwari, 2018, Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?, Hum Reprod Update, 24, 35, 10.1093/humupd/dmx031 Yovich, 2015, Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement, Reprod Biomed Online, 31, 180, 10.1016/j.rbmo.2015.05.005 Labarta, 2017, Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study, Hum Reprod, 32, 2437, 10.1093/humrep/dex316 Cédrin-Durnerin, 2019, Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium, Reprod Biomed Online, 38, 472, 10.1016/j.rbmo.2018.11.026 Gaggiotti-Marre, 2019, Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates, Gynecol Endocrinol, 35, 439, 10.1080/09513590.2018.1534952 Volovsky, 2020, Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles?, J Assist Reprod Genet Williams, 2000, Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates, Fertil Steril, 74, S209, 10.1016/S0015-0282(00)01336-4 Shapiro, 2014, Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts, Hum Reprod, 29, 1706, 10.1093/humrep/deu121 Haddad, 2007, Intramuscular route of progesterone administration increases pregnancy rates during non-downregulated frozen embryo transfer cycles, J Assist Reprod Genet, 24, 467, 10.1007/s10815-007-9168-z Kaser, 2012, Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer, Fertil Steril, 98, 1464, 10.1016/j.fertnstert.2012.08.007 Feinberg, 2013, Endometrin as luteal phase support in assisted reproduction, Fertil Steril, 99, 174, 10.1016/j.fertnstert.2012.09.019 Devine, 2018, Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial, Fertil Steril, 109, 266, 10.1016/j.fertnstert.2017.11.004 Alsbjerg, 2013, Increasing vaginal progesterone gel supplementation after frozen-thawed embryo transfer significantly increases the delivery rate, Reprod Biomed Online, 26, 133, 10.1016/j.rbmo.2012.10.012 Rashidi, 2016, Mansoureh Gorginzadehet. Oral dydrogesterone for luteal support in frozen-thawed embryo transfer artificial cycles: A pilot randomized controlled trial, Asian Pac J Reprod, 5, 490, 10.1016/j.apjr.2016.10.002 Zarei, 2017, Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial, Arch Gynecol Obstet, 295, 239, 10.1007/s00404-016-4217-4